Goldman Sachs
SURG icon

Goldman Sachs’s SurgePays SURG Stock Holding History

Goldman Sachs’s Portfolio SURG Stock Details SURG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,461
Closed -$57.4K – 6641
2025
Q2 		$57.4K Buy
18,461
+5,005
+37% +$13.9K ﹤0.01% 5895
2025
Q1 		$27.9K Buy
+13,456
New +$19.9K ﹤0.01% 5931
2024
Q1 		– Sell
-19,782
Closed -$128K – 5862
2023
Q4 		$128K Buy
19,782
+7,649
+63% +$40.7K ﹤0.01% 5255
2023
Q3 		$56.8K Sell
12,133
-15,186
-56% -$78.8K ﹤0.01% 5264
2023
Q2 		$200K Buy
+27,319
New +$163K ﹤0.01% 5180
2023
Q1 		– Sell
-12,900
Closed -$84.6K – 6217
2022
Q4 		$84.6K Buy
+12,900
New +$77.9K ﹤0.01% 5513

Other funds holding SURG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
MCA
Millennium Capital Advisors Little Rock, Arkansas $183M AUM 33.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return

Goldman Sachs's SURG Position: Q3 2025 in Review

Goldman Sachs sold out of SurgePays (SURG) in Q3 2025, closing a stake of 18,461 shares — an estimated $57.4K sold.

Goldman Sachs first reported a position in SURG in Q4 2022 and held it in 6 quarters. The position peaked at $200K in Q2 2023. 32 funds tracked by Wall St. Rank hold SURG as of Q3 2025.

  • Goldman Sachs reported no remaining SurgePays position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 18,461 SurgePays shares in Q3 2025, an estimated $57.4K.
  • Goldman Sachs first reported a position in SurgePays in Q4 2022 and held it in 6 quarters.
  • Goldman Sachs's SurgePays position peaked at $200K in Q2 2023.
  • 32 funds tracked by Wall St. Rank held SurgePays as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.